Zanubrutinib for the treatment of chronic lymphocytic leukemia

被引：0
|
作者：
Bruzzese, Antonella [1 ]
Martino, Enrica Antonia [1 ]
Labanca, Caterina [1 ]
Mendicino, Francesco [1 ]
Lucia, Eugenio [1 ]
Olivito, Virginia [1 ]
Neri, Antonino [2 ]
Morabito, Fortunato [3 ]
Vigna, Ernesto [1 ]
Gentile, Massimo [1 ,4 ,5 ]
机构：
[1] Azienda Osped Annunziata, Hematol Unit, Cosenza, Italy
[2] Sci Directorate IRCCS Reggio Emilia, Reggio Emilia, Italy
[3] AO Cosenza, Biotechnol Res Unit, Cosenza, Italy
[4] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
[5] Azienda Osped Annunziata, Hematol Unit, I-87100 Cosenza, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2023年 / 24卷 / 13期
关键词：
Zanubrutinb; CLL; therapy; BTKi; precision medicine; IBRUTINIB; OBINUTUZUMAB; VENETOCLAX; DISCONTINUATION;
D O I：
10.1080/14656566.2023.2229734
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1409 / 1413
页数：5
相关论文
共 50 条
  • [31] Treatment of chronic lymphocytic leukemia
    Janssens, Ann
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (01) : 44 - 50
  • [32] TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
    SILVER, RT
    SEMINARS IN HEMATOLOGY, 1969, 6 (04) : 344 - &
  • [33] Combined Therapy of Zanubrutinib and Zilovertamab in the Inhibition of Invasive Capability of Chronic Lymphocytic Leukemia Cells
    Hasan, Md Kamrul
    Widhopf, George F., II
    Kipps, Thomas J.
    BLOOD, 2023, 142
  • [34] Zanubrutinib: A Novel BTK Inhibitor in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
    Tam, Constantine S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 32 - 34
  • [35] BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia : a Single Arm Real-World Study
    Zhu, Huayuan
    Wu, Wei
    Sha, Yeqin
    Jin, Ze
    Yang, Yilian
    Qiu, Jingyan
    Ding, Chongyang
    Wang, Zhen
    Shi, Chuanbing
    Peng, Chen
    Mi, Hongling
    Chen, Ruize
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2021, 138
  • [36] Real-World Outcomes of Zanubrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Multicenter Retrospective Study
    Luo, Jing
    Zhang, Jiaojiao
    Liu, Ligen
    Wei, Rong
    Yao, Yonghua
    Xu, Min
    Xu, Jie
    Shi, Jumei
    Yang, Jianmin
    Hou, Jian
    Wang, Jin
    Mi, Jian-Qing
    BLOOD, 2023, 142
  • [37] Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
    Wei Xu
    Shenmiao Yang
    Keshu Zhou
    Ling Pan
    Zengjun Li
    Jianfeng Zhou
    Sujun Gao
    Daobin Zhou
    Jianda Hu
    Ru Feng
    Haiwen Huang
    Meng Ji
    Haiyi Guo
    Jane Huang
    William Novotny
    Shibao Feng
    Jianyong Li
    Journal of Hematology & Oncology, 13
  • [38] Bendamustine in the treatment of chronic lymphocytic leukemia
    Ujjani, Chaitra
    Cheson, Bruce D.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 617 - 623
  • [39] Current Treatment of Chronic Lymphocytic Leukemia
    Krzysztof Jamroziak
    Bartosz Puła
    Jan Walewski
    Current Treatment Options in Oncology, 2017, 18
  • [40] Ofatumumab for the treatment of chronic lymphocytic leukemia
    Grosicki, Sebastian
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (03) : 265 - 272
12345